8 reports

Monoclonal antibodies such as mepolizumab and omalizumab are sometimes effective.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • Trade

Monoclonal antibodies such as mepolizumab and omalizumab are sometimes effective.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • GlaxoSmithKline plc

Pasteur Institute NA NA MONOCLONAL ANTIBODY TO ANTAGONIZE FCGRIIA FOR AUTOIMMUNE ARTHRITIS, PULMONARY INFLAMMATION, SYSTEMIC ANAPHYLAXIS AND THROMBOCYTOPENIA - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description

  • Cough And Cold
  • Therapy
  • United States
  • World
  • Product Initiative

Most recently she served as the Worldwide Brand Director at Novartis Pharmaceuticals Corporation, where she was the global launch lead for Aimovig®, the first monoclonal antibody approved by the U. S.

  • Clinical Trial
  • Cough And Cold
  • HIV AIDS
  • United States
  • AcelRx Pharmaceuticals, Inc.

The drug candidate is a monoclonal antibody that inhibits binding of IL-## to the ST## receptor.

  • Cough And Cold
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

It also develops a product candidate, an anti-CD## monoclonal antibody that inhibits the production of adenosine produced by the tumor cells.

  • Cough And Cold
  • Pharmaceutical
  • Therapy
  • United States
  • Vernalis plc

Results from the Phase I study were presented at the ##th Annual Meeting of American Academy of Dermatology (AAD), 2017, with the title ##C A Phase ## Study of ANB##, an Anti-IL-## Monoclonal Antibody, in Healthy Volunteers".

  • Cough And Cold
  • Hospital
  • Therapy
  • United States
  • Product Initiative

The company" s product portfolio includes vaccines and antibody therapeutics with focus on infectious diseases, autoimmune diseases and cancer.

  • Anesthetics
  • Clinical Trial
  • Cough And Cold
  • Pharmaceutical
  • Opiant Pharmaceuticals, Inc.